Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme

Glioblastoma Multiforme (GBM) is the primary brain tumor and accounts for 200,000 deaths each year worldwide. The standard therapy includes surgical resection followed by temozolomide (TMZ)-based chemotherapy and radiotherapy. The survival period of GBM patients is only 12–15 months. Therefore, nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekala, Janaki Ramaiah, Adusumilli, Kowsalya, Chamarthy, Sahiti, Angirekula, Hari Sai Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227410/
https://www.ncbi.nlm.nih.gov/pubmed/37249862
http://dx.doi.org/10.1007/s11011-023-01234-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227410/
https://www.ncbi.nlm.nih.gov/pubmed/37249862
http://dx.doi.org/10.1007/s11011-023-01234-2

Ejemplares similares